Sex related differences in frequency, management and outcome of severe native valvular heart disease. Results from the ESC-EORP Valvular Heart Disease II survey

30 August 2024 (14:47 - 15:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Julia Mascherbauer

St. Poelten University Hospital, St Poelten (Austria)

5 More presentations in this session

Presentation thumbnail

Long-term structural valve deterioration after TAVI: insights from the European Valve Durability TAVI registry

Doctor C. Giannini (Pisa, IT)

Presentation thumbnail

Long-term benefit of isolated surgical tricuspid valve repair and replacement in patients with severe functional tricuspid regurgitation: Impact of the TRI-SCORE

Doctor J. Dreyfus (Saint-Denis, FR)

Presentation thumbnail

SAVR and TAVI comparison across the Globe based on current regional registry evidence - a meta-analysis of reconstructed time-to-event data

Professor T. Doenst (Jena, DE)

Presentation thumbnail

Aortic valve calcific volume by computed tomography angiography in patients with aortic stenosis

Doctor J. Geers (Jette, BE)

Presentation thumbnail

Serial volumetric assessment of ascending aort dilatation in severe aortic stenosis patients who receive Transcatheter aortic valve replacement: Comparison of bicuspid and tricuspid aortic stenosis

Doctor H. Kim (Seoul, KR)

Access the full session

Session thumbnail

Registries, observational, and other studies on TAVI

The Event

Event poster

ESC Congress 2024

30 August 2024 14:47 CET

You may be interested in

Congress Session

Young Investigator Award Session in Valvular Heart Disease

Congress Presentation

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: A subanalysis from the DEDICATE-DZHK6 trial

Congress Presentation

Sex-specific considerations of TAVI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources